Europe Renal Denervation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Renal Denervation Devices Market Analysis

The European renal denervation devices market was valued at USD 56.92 million in the base year and is expected to register a CAGR of 37.36% over the forecast period.

The pandemic impacted the European renal denervation devices market initially. With the outbreak of COVID-19, the European renal denervation devices market experienced a moderate decline in growth. It was primarily due to the temporary cancellation of treatment and elective procedures of the non-COVID medical condition, such as cardiology and vascular procedures, which includes renal denervation procedures. The pandemic shifted most of the focus of healthcare and research on COVID-19-related diagnosis and treatment, adversely impacting the region's cardiology and vascular specialties. For instance, a study published in the European Heart Journal - Quality of Care and Clinical Outcomes by researchers of Keele University, United Kingdom, in May 2021 highlighted the significant decrease in cardiac procedures in the United Kingdom. The study stated that 45,000 procedures were postponed amid the pandemic. However, in the post-pandemic period, the number of COVID-19-positive patients decreased. Also, the lifting of the lockdown and gradual resumption of the elective procedure of the cardiology, vascular, and other non-COVID medical areas are expected to restore the normal growth rate of the market. For instance, a study published in the European Journal of Vascular and Endovascular Surgery in October 2022 highlighted the recovery and resumption of vascular procedures after the pandemic in the region. The study mentioned that most of the services have rebounded to the pre-pandemic level with the introduction of protocols for the management of the peri-operative COVID-19 risk. Thus, the COVID-19 outbreak adversely impacted the market's growth in its preliminary phase. Moreover, the market is expected to grow at a stable pace with the increasing number of procedures for renal denervation in Europe.

Furthermore, the market is expected to grow, owing to the factors, such as technological advancements, the rising prevalence of hypertension, and the long-lasting effects of the renal denervation procedure.

The prevalence of hypertension is on the rise in the European Region, which is expected to create more demand for renal denervation procedures and devices for the management of the fatality of the disease. For instance, as per the data published by the British Heart Foundation in April 2023, more than 10 million individuals in the United Kingdom have been diagnosed with high blood pressure in 2022. The adversity of the high burden of hypertension is also found in the young population as well in the regions. The renal denervation procedure has been demonstrated to be highly efficient for the long-term management of hypertension. Thus, with such benefits, efficacy, and safety of renal denervation procedures for managing hypertension, the demand for renal denervation devices is likely to increase as more procedures are performed in Europe.

Additionally, another study published in the Clinical Research in Cardiology by the researchers of Erasmus University Medical Center, the Netherlands, in July 2022 underlined the high significance of renal denervation procedure in decreasing the blood pressure of hypertension patients in a few months and putting them off of the antihypertensive drugs. The study demonstrated that the renal denervation procedure maintained the blood pressure for five years in the operated hypertension patients. The procedure also decreased the ambulatory daytime without antihypertensive drug therapy over the period. Further, a study published in the Journal of Medicine by researchers at Vilnius University, Lithuania, highlighted the long-term antihypertensive effects of renal denervation. Thus, with the increasing cases of hypertension and the long-term benefits of renal denervation, the market for renal denervation devices is expected to grow further during the forecast period in Europe.

However, the painful procedure and stringent approval process for renal denervation devices and reimbursement systems will likely impede market growth.

Europe Renal Denervation Devices Market Trends

The Ultrasound-based Segment is Expected to Witness Significant Growth Over the Forecast Period

Europe Renal Denervation Devices Industry Segmentation

As per the scope of this report, renal denervation devices are catheters that burn the nerve in the renal arteries using by ablating it. It is a minimally invasive procedure that involves the removal of nerves from the renal artery that leads to the kidneys. It helps in regulating vasoconstriction, which optimizes the blood flow into the kidney. The European renal denervation devices market is segmented into by Technology (Radiofrequency-based, Ultrasound-based, and Micro-infusion-based) and Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The report offers the value in USD million for the above segments.